These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2835815)
61. [Effects of pre-operative intrahepatic-arterial infusion in liver cancer with special reference to hepatic resection]. Okuyama K; Onoda S; Yamamoto Y; Tohnosu N; Koide Y; Matsubara H; Matsubara H; Kinoshita H; Sano T; Ryu M Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2414-8. PubMed ID: 2843107 [TBL] [Abstract][Full Text] [Related]
62. [Continuous arterial infusion of low-dose cisplatin, 5-fluorouracil as adjuvant therapy in cytoreductive surgery for advanced hepatocellular carcinoma]. Ogata T; Okuda K; Tanaka S; Shibata J; Koga A; Kinoshita H; Nakayama T; Aoyagi S; Tanaka M; Tanikawa K Gan To Kagaku Ryoho; 1997 Sep; 24(12):1661-4. PubMed ID: 9382501 [TBL] [Abstract][Full Text] [Related]
63. [Transcatheter arterial embolization for advanced hepatocellular carcinoma--indications and limitations]. Nakamura H; Kawata S; Takamura M; Osuga K; Murakami T Gan To Kagaku Ryoho; 2000 Sep; 27(10):1509-15. PubMed ID: 11015994 [TBL] [Abstract][Full Text] [Related]
64. [Three cases of hepatocellular carcinoma, over 3 cm in diameter, with liver cirrhosis treated with combination of radiofrequency ablation and continuous hepatic arterial infusion chemotherapy]. Hirashita T; Nakashima K; Sakai M; Sakai I Gan To Kagaku Ryoho; 2007 Jul; 34(7):1123-6. PubMed ID: 17637554 [TBL] [Abstract][Full Text] [Related]
65. [Transcatheter arterial chemoembolization combined with other therapies for the treatment of primary hepatic carcinoma: a review]. Chen HY; Chen Z Zhong Xi Yi Jie He Xue Bao; 2008 Apr; 6(4):422-6. PubMed ID: 18405614 [No Abstract] [Full Text] [Related]
66. [Efficacy of repeated hepatic dearterialization combined with intra-arterial infusion chemotherapy for unresectable tumors of the liver]. Hashimoto N; Kohno H; Kubota H; Hayashi T; Uchida M; Yamanoi A; Ono T; Nagasue N Gan To Kagaku Ryoho; 1995 Sep; 22(11):1586-9. PubMed ID: 7574766 [TBL] [Abstract][Full Text] [Related]
67. Treatment of hepatocellular carcinoma (HCC) by intra-arterial infusion of radio-emitter compounds: trans-arterial radio-embolisation of HCC. Andreana L; Isgrò G; Marelli L; Davies N; Yu D; Navalkissoor S; Burroughs AK Cancer Treat Rev; 2012 Oct; 38(6):641-9. PubMed ID: 22169503 [TBL] [Abstract][Full Text] [Related]
68. [Multidisciplinary treatment of unresectable liver cancer]. Saeki T; Kuninobu H; Kodama H; Nishiyama M; Yoshinaka K; Toge T; Niimoto M; Hattori T Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2583-9. PubMed ID: 2843127 [TBL] [Abstract][Full Text] [Related]
69. High dose chemotherapy with autologous marrow transplantation for advanced gastrointestinal adenocarcinomas. Kessinger A Dig Dis; 1986; 4(4):203-7. PubMed ID: 3555893 [No Abstract] [Full Text] [Related]
70. Hepatic-directed Therapies in Patients with Neuroendocrine Tumors. Kennedy AS Hematol Oncol Clin North Am; 2016 Feb; 30(1):193-207. PubMed ID: 26614377 [TBL] [Abstract][Full Text] [Related]
71. [Studies of hemodynamics of hepatocellular carcinoma by Tc 99 m-MAA scintigraphy--especially effects of hepatic arterial occlusion]. Yano S; Tarumi T; Tamura K; Nakase A Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1248-56. PubMed ID: 2852703 [No Abstract] [Full Text] [Related]
72. [A case of hepatoma effectively treated by TAE and intra-arterial and intraportal infusion chemotherapy]. Sato M; Watanabe Y; Sakai K; Iwamura F; Kimura S Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1318-24. PubMed ID: 3023506 [No Abstract] [Full Text] [Related]
73. [What changes were made in the National Thesaurus of Gastrointestinal Cancer in 2005?]. Legoux JL; Bedenne L; Seitz JF; Pezet D; Rougier P; Bouché O; Barbare JC; André T; Malka D; Cadiot G; Ruskoné-Foumestraux A; Landi B; Peiffert D; Ducreux M; Louvet C; Dorval E Gastroenterol Clin Biol; 2006 Oct; 30(10):1191-5. PubMed ID: 17075477 [No Abstract] [Full Text] [Related]
74. New Paradigm in Gastrointestinal Cancer Treatment. Kudo M Oncology; 2017; 93 Suppl 1():1-8. PubMed ID: 29258099 [No Abstract] [Full Text] [Related]
75. A translational worldwide perspective for liver cancer - First International Meeting. Feitelson MA IDrugs; 2007 Sep; 10(9):630-2. PubMed ID: 17786845 [No Abstract] [Full Text] [Related]
76. Report from the Western Canadian Gastrointestinal Cancer Consensus Conference Virtual Education Series-Transition from Local to System Therapy and Optimal Sequencing of Systemic Therapy for HCC. Zaidi A; Ahmed S; Ahmed S; Brunet B; Davies J; Doll C; Dueck DA; Gordon V; Hebbard P; Kim C; Le D; Lee-Ying R; Lim H; Liu D; McGhie JP; Mulder K; Park J; Renouf D; Schellenberg D; Wong RPW; Moser M Curr Oncol; 2021 Oct; 28(6):4317-4327. PubMed ID: 34898545 [TBL] [Abstract][Full Text] [Related]
77. The role of multimodal therapy in the treatment of hepatocellular carcinoma. Farmer DG; Busuttil RW Cancer; 1994 Jun; 73(11):2669-70. PubMed ID: 8194002 [No Abstract] [Full Text] [Related]
78. [Systemic therapy for hepatocellular carcinoma:recent advances and future perspective]. Kudo M Nihon Shokakibyo Gakkai Zasshi; 2019; 116(1):8-17. PubMed ID: 30626857 [No Abstract] [Full Text] [Related]
79. Successes and Failures of Combined Modalities in Upper Gastrointestinal Malignancies: New Directions. Jamorabo DS; Lin SH; Jabbour SK Semin Radiat Oncol; 2016 Oct; 26(4):307-19. PubMed ID: 27619252 [TBL] [Abstract][Full Text] [Related]
80. Multimodal treatment and prognostic factors in GI cancer--introduction. Siewert JR; Fink U World J Surg; 1995; 19(2):167. PubMed ID: 7754618 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]